Compounds > resveratrol

Page last updated: 2024-08-16

resveratrol and Pulmonary Fibrosis

resveratrol has been researched along with Pulmonary Fibrosis in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (5.26)	29.6817
2010's	10 (52.63)	24.3611
2020's	8 (42.11)	2.80

Authors

Authors	Studies
Abou Nazel, MW; Albanawany, NM; El-Moslemany, RM; Elsawy, SM; Samy, DM; Zahran, N	1
Huang, Y; Jiang, W; Shao, M; Wang, L	1
Bao, L; Chen, X; Fan, X; Li, W; Liu, N; Shao, Y; Wang, H; Ye, J; Zhao, D	1
Li, L; Li, Q; Liu, B; Liu, L; Zhou, X	1
Arora, N; Gautam, A; Kapoor, H; Nagar, E; Singh, N	1
Cheriet, T; Eid, AH; Giordo, R; Pintus, G; Posadino, AM; Ramli, I; Zayed, H	1
Amini, P; Farhood, B; Motevaseli, E; Musa, AE; Najafi, M; Pooladvand, V; Saffar, H; Shabeeb, D; Yahyapour, R	1
Chen, H; Han, L; Ji, X; Li, X; Mao, J; Miu, Y; Wang, J; Wang, Q; Wang, Z; Wei, L; Zhang, Z	1
Chen, L; He, F; Jin, S; Li, Q; Lin, J; Ma, S; Mei, J; Wang, J; Yu, J; Zhang, H; Zheng, H	1
Amini, P; Azmoonfar, R; Khodamoradi, E; Motevaseli, E; Musa, AE; Najafi, M; Rezaeyan, A; Shabeeb, D; Tavassoli, A; Yahyapour, R	1
Bai, L; Ding, S; Wang, H; Wang, M; Wu, W; Yu, P	1
Dong, WW; Jiang, L; Liu, YJ; Mao, YF; Zhang, YQ; Zhu, XY	1
Alcaide, A; Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Impellizzeri, D; Maria Zubelia, J; Motilva, V; Siracusa, R; Talero, E	1
Hu, D; Rong, L; Wang, W; Wu, J; Xu, XW; Zhao, RP	1
Feghali-Bostwick, C; Gongora, R; Lasky, JA; Sanchez, CG; Sosulski, ML	1
Chen, J; Han, X; Liu, R; Lu, Y; Peng, D; Song, G; Xia, Y; Yang, X; Zhang, W; Zhu, J	1
Conte, E; Crimi, N; Fagone, E; Fruciano, M; Gili, E; Giuffrida, R; Lo Furno, D; Pistorio, MP; Vancheri, C	1
Akgedik, R; Akgedik, S; Armutcu, F; Bozkurt, B; Karamanlı, H; Ozol, D; Uysal, S; Yıldırım, Z	1
Ercan, F; Gedik, N; Sehirli, AO; Sener, G; Topaloğlu, N	1

Reviews

1 review(s) available for resveratrol and Pulmonary Fibrosis

Article	Year
Potential Therapeutic Targets of Resveratrol in the Prevention and Treatment of Pulmonary Fibrosis. Frontiers in bioscience (Landmark edition), 2023, 09-14, Volume: 28, Issue:9 Topics: Arthritis, Rheumatoid; Humans; Lung Diseases, Interstitial; Pulmonary Fibrosis; Resveratrol; Scleroderma, Systemic	2023

Other Studies

18 other study(ies) available for resveratrol and Pulmonary Fibrosis

Article	Year
Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats. Drug delivery, 2022, Volume: 29, Issue:1 Topics: Acute Lung Injury; Animals; Bleomycin; Nanocapsules; Pulmonary Fibrosis; Rats; Resveratrol	2022
Resveratrol alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and down-regulating TLR4/NF-κB and TGF-β1/smad3 signalling pathways in rats. Tissue & cell, 2022, Volume: 79 Topics: Animals; Bleomycin; Epithelial-Mesenchymal Transition; NF-kappa B; Pulmonary Fibrosis; Rats; Resveratrol; Toll-Like Receptor 4; Transforming Growth Factor beta1	2022
Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy-Lysosome Pathway. Molecules (Basel, Switzerland), 2022, Dec-02, Volume: 27, Issue:23 Topics: Animals; Arthritis, Rheumatoid; Autophagy; Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis; Resveratrol	2022
Effects of Resveratrol on Pulmonary Fibrosis via TGF-β/Smad/ERK Signaling Pathway. The American journal of Chinese medicine, 2023, Volume: 51, Issue:3 Topics: Animals; Inflammation; Pulmonary Fibrosis; Rats; Resveratrol; RNA; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta	2023
Resveratrol mitigates miR-212-3p mediated progression of diesel exhaust-induced pulmonary fibrosis by regulating SIRT1/FoxO3. The Science of the total environment, 2023, Dec-01, Volume: 902 Topics: Animals; Cytokines; Mice; Mice, Inbred C57BL; MicroRNAs; Pulmonary Fibrosis; Resveratrol; Sirtuin 1; Transforming Growth Factor beta; Vehicle Emissions	2023
Protective Effect of Metformin, Resveratrol and Alpha-lipoic Acid on Radiation- Induced Pneumonitis and Fibrosis: A Histopathological Study. Current drug research reviews, 2019, Volume: 11, Issue:2 Topics: Animals; Antioxidants; Dose-Response Relationship, Drug; Hypoglycemic Agents; Lung; Male; Metformin; Mice; Neutrophil Infiltration; Pulmonary Fibrosis; Radiation Injuries; Radiation Pneumonitis; Radiation-Protective Agents; Resveratrol; Thioctic Acid	2019
Resveratrol alleviates bleomycin-induced pulmonary fibrosis via suppressing HIF-1α and NF-κB expression. Aging, 2021, 01-20, Volume: 13, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Bleomycin; Cell Line; Dexamethasone; Glucocorticoids; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; NF-kappa B; Pulmonary Fibrosis; Random Allocation; Rats; Resveratrol	2021
Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 105 Topics: Animals; Antioxidants; Disease Models, Animal; Female; Gene Expression Regulation; Male; MAP Kinase Signaling System; MicroRNAs; Pulmonary Fibrosis; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Transcription Factor AP-1	2018
Mitigation of Radiation-induced Pneumonitis and Lung Fibrosis using Alpha-lipoic Acid and Resveratrol. Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2020, Volume: 19, Issue:2 Topics: Animals; Antioxidants; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Mice; Pulmonary Fibrosis; Radiation; Radiation Pneumonitis; Resveratrol; Thioctic Acid	2020
Resveratrol alleviates chronic "real-world" ambient particulate matter-induced lung inflammation and fibrosis by inhibiting NLRP3 inflammasome activation in mice. Ecotoxicology and environmental safety, 2019, Oct-30, Volume: 182 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Enzyme Inhibitors; Fibrosis; Inflammasomes; Leucine-Rich Repeat Proteins; Lung; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Particulate Matter; Pneumonia; Proteins; Pulmonary Fibrosis; Resveratrol; Signal Transduction; Transforming Growth Factor beta1	2019
Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling. Clinical nutrition (Edinburgh, Scotland), 2015, Volume: 34, Issue:4 Topics: Animals; Catalase; Collagen Type I; Disease Models, Animal; Epithelial-Mesenchymal Transition; Lipopolysaccharides; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Oxidative Stress; Pulmonary Fibrosis; Resveratrol; Signal Transduction; Stilbenes; Superoxide Dismutase; Transforming Growth Factor beta1	2015
Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice. The British journal of nutrition, 2015, Sep-28, Volume: 114, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Dietary Supplements; Disease Models, Animal; Lung; Male; Mangifera; Mice, Inbred ICR; Neutrophil Infiltration; Plant Extracts; Plant Leaves; Polyphenols; Pulmonary Fibrosis; Quercetin; Random Allocation; Respiratory Mucosa; Resveratrol; Stilbenes; Vitis; Xanthones	2015
Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT). European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:10 Topics: Animals; Bleomycin; Cadherins; Enzyme Activation; Epithelial-Mesenchymal Transition; Mice; Pulmonary Fibrosis; Resveratrol; Sirtuin 1; Stilbenes	2016
Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis. The journals of gerontology. Series A, Biological sciences and medical sciences, 2017, May-01, Volume: 72, Issue:5 Topics: Aging; Animals; Cell Differentiation; Disease Models, Animal; Down-Regulation; Fibroblasts; Humans; Isocitrate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Pulmonary Fibrosis; Resveratrol; Sirtuin 3; Smad3 Protein; Stilbenes; Superoxide Dismutase; Transforming Growth Factor beta1	2017
Therapeutic Effects of Resveratrol in a Mouse Model of LPS and Cigarette Smoke-Induced COPD. Inflammation, 2016, Volume: 39, Issue:6 Topics: Animals; Beclin-1; Bronchoalveolar Lavage Fluid; Cytokines; Lipopolysaccharides; Lung; Mice; Mucus; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Resveratrol; Smoke; Stilbenes	2016
Resveratrol inhibits transforming growth factor-β-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration. Experimental lung research, 2011, Volume: 37, Issue:3 Topics: Actins; Cell Differentiation; Cell Line; Cell Proliferation; Collagen; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Gene Expression; Humans; Lung; Myofibroblasts; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pulmonary Fibrosis; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Transforming Growth Factor beta	2011
Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats. Inflammation, 2012, Volume: 35, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Count; Hydroxyproline; Idiopathic Pulmonary Fibrosis; Lung; Male; Malondialdehyde; Oxidative Stress; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Wistar; Resveratrol; Stilbenes	2012
Resveratrol alleviates bleomycin-induced lung injury in rats. Pulmonary pharmacology & therapeutics, 2007, Volume: 20, Issue:6 Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antioxidants; Bleomycin; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Glutathione; Lipid Peroxidation; Lung; Male; Malondialdehyde; Neutrophil Infiltration; Peroxidase; Pulmonary Fibrosis; Rats; Rats, Wistar; Resveratrol; Stilbenes	2007